Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study
Open Access
- 27 February 2009
- journal article
- Published by Springer Nature in Malaria Journal
- Vol. 8 (1), 36
- https://doi.org/10.1186/1475-2875-8-36
Abstract
Cerebral malaria (CM) is associated with high mortality and morbidity caused by a high rate of transient or persistent neurological sequelae. Studies on immunomodulatory and neuroprotective drugs as ancillary treatment in murine CM indicate promising potential. The current study was conducted to evaluate the efficacy of glatiramer acetate (GA), an immunomodulatory drug approved for the treatment of relapsing remitting multiple sclerosis, in preventing the death of C57Bl/6J mice infected with Plasmodium berghei ANKA. GA treatment led to a statistically significant lower risk for developing CM (57.7% versus 84.6%) in treated animals. The drug had no effect on the course of parasitaemia. The mechanism of action seems to be an immunomodulatory effect since lower IFN-gamma levels were observed in treated animals in the early course of the disease (day 4 post-infection) which also led to a lower number of brain sequestered leukocytes in treated animals. No direct neuro-protective effect such as an inhibition of apoptosis or reduction of micro-bleedings in the brain was found. These findings support the important role of the host immune response in the pathophysiology of murine CM and might lead to the development of new adjunctive treatment strategies.Keywords
This publication has 50 references indexed in Scilit:
- Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malariaMalaria Journal, 2008
- Expression Microarray Analysis Implicates Apoptosis and Interferon-Responsive Mechanisms in Susceptibility to Experimental Cerebral MalariaThe American Journal of Pathology, 2007
- Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian childrenMalaria Journal, 2007
- Apoptosis in experimental cerebral malaria: spatial profile of cleaved caspase‐3 and ultrastructural alterations in different disease stagesNeuropathology and Applied Neurobiology, 2007
- Conventional and experimental treatment of cerebral malariaInternational Journal for Parasitology, 2006
- Therapy with glatiramer acetate for multiple sclerosisPublished by Wiley ,2003
- Steroids for treating cerebral malariaCochrane Database of Systematic Reviews, 1999
- Copolymer 1 reduces relapse rate and improves disability in relapsing‐remitting multiple sclerosisNeurology, 1995
- Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation.The Journal of Experimental Medicine, 1993
- Dexamethasone Proves Deleterious in Cerebral MalariaNew England Journal of Medicine, 1982